(41) explored a noninvasive approach to reveal IDH1 status by a quantitative radiomic approach in grade II gliomas, and the result showed that radiomics is a potentially useful method to estimate IDH1 mutation status noninvasively using conventional T2-Flair MRI images. The gene discussed is IDH1; the disease is central nervous system cancer.